Trial Profile
Study of low dose valgancicolvir for the treatment of cytomegalovirus disease in patients with kidney transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Dec 2015
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 20 Dec 2015 New trial record